Publicaciones en las que colabora con José Luís Arias Jiménez (6)

2012

  1. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers

    British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650

2011

  1. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283

2008

  1. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

    Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608

2007

  1. Prevalencia de resistencia a fármacos antirretrovirales en España

    Anales de Pediatria, Vol. 67, Núm. 2, pp. 104-108

2004

  1. Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children

    AIDS, Vol. 18, Núm. 2, pp. 247-255

2001

  1. Vertical transmission of HIV-1 variants resistant to reverse transcriptase and protease inhibitors

    Archives of Internal Medicine, Vol. 161, Núm. 22, pp. 2738-2739